Form 4 for MLYS Mineralys Therapeutics, Inc.
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001628280-23-003924 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-16 | 2023-02-14 | MLYS | Levy Adam Scott | CFO, Chief Bus. Off, Secy | P - Purchase | $16.00 | +6,250 | 350.8K | +2% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | P | A | 6,250 | $16.00 | 350,811 | D | — | — |